1. Home
  2. HAS vs PRME Comparison

HAS vs PRME Comparison

Compare HAS & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$80.50

Market Cap

13.2B

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.81

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
PRME
Founded
1923
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
536.4M
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
HAS
PRME
Price
$80.50
$3.81
Analyst Decision
Strong Buy
Buy
Analyst Count
11
6
Target Price
$109.73
$7.56
AVG Volume (30 Days)
1.8M
3.4M
Earning Date
05-20-2026
05-08-2026
Dividend Yield
2.98%
N/A
EPS Growth
N/A
18.18
EPS
1.39
N/A
Revenue
$5,365,900,000.00
$4,632,000.00
Revenue This Year
$5.38
$7.06
Revenue Next Year
$6.48
$47.01
P/E Ratio
$57.60
N/A
Revenue Growth
13.06
55.28
52 Week Low
$69.50
$2.67
52 Week High
$106.98
$6.94

Technical Indicators

Market Signals
Indicator
HAS
PRME
Relative Strength Index (RSI) 33.51 65.67
Support Level $79.45 $3.16
Resistance Level $84.30 $4.04
Average True Range (ATR) 1.97 0.29
MACD -0.01 0.10
Stochastic Oscillator 6.05 71.15

Price Performance

Historical Comparison
HAS
PRME

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to 19 million digital tabletop players.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: